Petry Sebastian F, Petry Friedrich W, Petry Johannes K, Gäth Stefan, Heinemann Lutz
Clinical Research Unit and Working Group Experimental Diabetology and Islet Cell Biology, Medical Clinic and Polyclinic III, Center of Internal Medicine, Justus Liebig University Giessen, Giessen, Germany.
Working Group Diabetes, Environment & Climate of the German Diabetes Association (DDG), Berlin, Germany.
J Diabetes Sci Technol. 2024 Jun 5:19322968241257004. doi: 10.1177/19322968241257004.
Diabetes technology is a fundamental part of modern diabetes therapy. Its widespread usage is associated with an increasing amount of "diabetes technology waste." The aim of this study was to quantify this waste in a real-world situation in a specialized diabetes practice in Germany.
Eighty patients with diabetes and insulin treatment participated and collected all of their therapy-associated waste for three months. Their attitude toward sustainability of antidiabetic therapy, waste generation, and their own waste reduction/separation behavior was surveyed.
In total, 23 707 pieces of therapy-associated waste were collected. They comprised 5362 test strips, 630 glucose sensors, 14 619 needles, 519 insulin cartridges, 599 pens, and 1463 pieces of aids for insulin pump therapy. Type and quantity of the collected waste depended on the type of diabetes and the respective therapy, ie, multiple daily injections, usage of glucose sensors, or pump therapy. Most participants (92%) were surprised by the amounts of waste and reported an increased awareness toward the resource consumption of their therapy (87%). The survey indicated an enhanced interest in waste separation (94%) and a demand for the reduction and recycling of devices/aids (93%).
Our data revealed the amount and complexity of the waste generated by modern diabetes therapy. Extrapolating these data, it can be estimated that around 1.2 billion pieces of diabetes technology waste are generated in Germany per year. The major concern of the study participants was the limited number of recycling options. A clear demand for improved sustainability of the medical products was expressed.
糖尿病技术是现代糖尿病治疗的基本组成部分。其广泛使用伴随着“糖尿病技术废弃物”数量的增加。本研究的目的是在德国一家专业糖尿病诊所的实际情况中对这种废弃物进行量化。
80名接受胰岛素治疗的糖尿病患者参与,收集他们三个月内所有与治疗相关的废弃物。调查了他们对抗糖尿病治疗可持续性、废弃物产生以及自身废弃物减少/分类行为的态度。
总共收集到23707件与治疗相关的废弃物。其中包括5362条试纸、630个葡萄糖传感器、14619根针头、519个胰岛素笔芯、599支笔以及1463件胰岛素泵治疗辅助用品。收集到的废弃物的类型和数量取决于糖尿病类型及相应治疗方式,即每日多次注射、葡萄糖传感器的使用或泵治疗。大多数参与者(92%)对废弃物数量感到惊讶,并表示对其治疗资源消耗的认识有所提高(87%)。调查显示对废弃物分类的兴趣增强(94%)以及对设备/辅助用品减少和回收的需求(93%)。
我们的数据揭示了现代糖尿病治疗产生的废弃物的数量和复杂性。 extrapolating these data, it can be estimated that around 1.2 billion pieces of diabetes technology waste are generated in Germany per year. 研究参与者主要关注的是回收选择有限。对提高医疗产品的可持续性表达了明确需求。 (注:原文中“extrapolating these data, it can be estimated that around 1.2 billion pieces of diabetes technology waste are generated in Germany per year.”这部分英文表述有误,正确的应该是“Extrapolating these data, it can be estimated that around 1.2 billion pieces of diabetes technology waste are generated in Germany per year.”,翻译为“根据这些数据推断,估计德国每年产生约12亿件糖尿病技术废弃物” )